BLOG

Fen Phen Causing Primary Pulmonary Hypertension


PPH caused By Fen Phen
PPH caused By Fen Phen

Are you one of the millions of consumers who used the drug manufactured by Wyeth called Fen Phen?  It has been determined that approximately 30 per cent of patients who have used the combined drugs, Fen Phen, have experienced irregular echocardiogram results.

More than 6 million people have used the diet drug combination Fen Phen and in the United States, an estimated 500 to 1,000 new cases of primary pulmonary hypertension are diagnosed each year. If you did use Fen Phen and you have subsequently been diagnosed with primary pulmonary hypertension (PPH) or you have been exhibiting any of the symptoms associated with the disease you should act to protect your legal rights immediately.

Patients now suffering from primary pulmonary hypertension caused by Fen Phen must file individual lawsuits in order to make their legal claim. To retain your legal rights, please contact Nadrich & Cohen at 1.800.718.4658 for an immediate consultation and speak with a PPH Lawyer right away, we can help you preserve your rights.

Primary Pulmonary Hypertension Varies Greatly Among Patients

Primary pulmonary hypertension is a lung disorder in which the blood pressure in the pulmonary artery rises to extremely high levels for no apparent reason. The pulmonary artery is a blood vessel that carries oxygen poor blood from the right ventricle of the heart to the lungs. Hypertension is a medical term for high blood pressure.

The blood picks up oxygen in the lungs then the blood flows to the heart’s left side, where the left ventricle pumps it throughout the rest of the body by way of the aorta. The severity of pulmonary hypertension among patients varies greatly.

PPH Diagnosis Can Be Complex

Evaluating and accurately diagnosing and treating the condition can be very complex so patients with symptoms that suggest that they may have primary pulmonary hypertension require a complete evaluation by a physician with expertise and experience in pulmonary hypertension.

Normal average pulmonary artery pressure is about 14 mm Hg while resting. In patients with PPH, the average blood pressure in the pulmonary artery is greater than 25 mm Hg at rest and greater than 30 mm Hg during exercise. This abnormally high pressure is associated with changes that occur in the small blood vessels in the lungs.

These changes increase the resistance to blood flowing through the small blood vessels. This increased resistance puts a strain on the right ventricle, forcing it to work much harder than usual to move enough blood through the lungs.

Contact Fen Phen Lawyer

If you decide to file a lawsuit, you could be compensated for all of your medical expenses as well as any income loss due to PPH, you can even be compensated for your pain and suffering. Compensation for the death of a loved one who has succumbed to Primary Pulmonary Hypertension Caused By Fen Phen is also possible. If you or a loved one are currently suffering from Primary Pulmonary Hypertension caused by Fen Phen please contact a qualified personal injury lawyer today at The Law Offices of Nadrich and Cohen, we can help you.

Learn More...


February 23, 2012

Fen Phen Users Need to Recognize Primary Pulmonary Hypertension Symptoms

The once-popular diet drug fen phen has been linked to serious side effects, inc...


February 14, 2012

Fen Phen Side Effects Lawsuit: Do You Have a Claim?

In the 1990s, a new weight loss drug known as fen phen experienced a brief but i...


July 2, 2010

Fen Phen Causing Primary Pulmonary Hypertension

Are you one of the millions of consumers who used the drug manufactured by Wyeth...

Do I Have A Case?

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

 

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

 

Why
Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


October 15, 2019

Zantac Recalled In All Markets

GlaxoSmithKline said on October 8, 2019 that it was recalling their popular heartburn medication Zantac in all markets as a precaution. This comes mere days after the U.S. Food and Drug Administration (FDA) found “unacceptable” levels of the carcinogen NDMA in the medicine.


October 2, 2019

Hidden FDA Database Concealed Reports of Surgical Stapler Malfunctions

A hidden FDA database of medical device failures was shut down in June 2019. The database contains medical device reports submitted to the FDA via its Alternative Summary Reporting Program from 1999 to 2019. Reports which were sent to this database were not, until recently, made public. The Alternative Summary Reporting Program is a non-public database, unlike the FDA’s MAUDE database which publicly logs medical device failures or defects for public review.

 

We are Personal Injury Lawyers representing accident victims throughout California.
For 30 years, the law firm of Nadrich & Cohen, LLP has helped injury victims
obtain the compensation they deserve.